Analyst Ratings for AstraZeneca (AZN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/7/2011 | Morgan Stanley | N/A | Downgrade | Underweight (N/A) |
N/A (N/A) |
47.77 (45.43) |
-4.9% | Details |
| 7/22/2011 | BofA/Merrill Lynch | N/A | Downgrade | Neutral (N/A) |
N/A (N/A) |
50.48 (45.43) |
-10% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
